Showing results (131-140 of 138) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Frontiers in Immunology|July 2, 2025
Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten yearsLúcia Mamede, Roser Cantenys Sabà, Samya Van Coillie, et al.Scientific Data|June 27, 2024
A large-scale and PCR-referenced vocal audio dataset for COVID-19Jobie Budd, Kieran Baker, Emma Karoune, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2023
A wearable device perspective on the standard definitions of disability progression in multiple sclerosisGloria Dalla Costa, Carlos Nos, Ana Zabalza, et al.Journal of Affective Disorders|August 20, 2023
Multilingual markers of depression in remotely collected speech samples: A preliminary analysisNicholas Cummins, Judith Dineley, Pauline Conde, et al.Journal of Affective Disorders|March 29, 2024
Identifying depression-related topics in smartphone-collected free-response speech recordings using an automatic speech recognition system and a deep learning topic modelYuezhou Zhang, Amos A Folarin, Judith Dineley, et al.Journal of Consulting and Clinical Psychology|March 24, 2025
Brief use of behavioral activation features predicts benefits of self-help app on depression symptoms: Secondary analysis of a selective prevention trial in young peopleEmily Bralee, Mohammod Mostazir, Fiona C Warren, et al.The Lancet. Digital Health|October 5, 2024
Emotional competence self-help mobile phone app versus cognitive behavioural self-help app versus self-monitoring app to promote mental wellbeing in healthy young adults (ECoWeB PROMOTE): an international, multicentre, parallel, open-label, randomised controlled trialEdward R Watkins, Fiona C Warren, Alexandra Newbold, et al.The Lancet. Digital Health|October 5, 2024
Emotional competence self-help app versus cognitive behavioural self-help app versus self-monitoring app to prevent depression in young adults with elevated risk (ECoWeB PREVENT): an international, multicentre, parallel, open-label, randomised controlled trialEdward R Watkins, Fiona C Warren, Alexandra Newbold, et al.Pageof 14